CA Stock MarketDetailed Quotes
ZRO Biosenta Inc
- 0.175
- +0.040+29.63%
15min DelayMarket Closed Sep 11 10:12 ET
5.58MMarket Cap-729P/E (TTM)
0.175High0.175Low1.14KVolume0.175Open0.135Pre Close199.85Turnover0.89052wk High0.01%Turnover Ratio31.86MShares0.13552wk Low-0.24EPS TTM2.83MFloat Cap9.900Historical HighLossP/E (Static)16.15MShs Float0.010Historical Low-0.24EPS LYR0.00%Amplitude--Dividend TTM-0.78P/B1Lot Size--Div YieldTTM
Biosenta Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -19.97%-196.87K | -120.11%-180.93K | -93.12%-347.77K | -9.19%-550.79K | -0.45%-124.42K | 8.67%-164.09K | -189.49%-82.2K | 38.49%-180.08K | 24.97%-504.43K | 53.28%-123.86K |
| Net income from continuing operations | -10.69%-547.3K | -47.00%-495.07K | -94.81%-471.14K | -332.00%-6.3M | -443.39%-5.23M | -75.08%-494.46K | 84.33%-336.77K | 55.89%-241.84K | 28.58%-1.46M | 560.28%1.52M |
| Operating gains losses | ---- | ---- | ---- | --4.79M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --700 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | -88.75%3.46K | ---- | ---- | ---- | ---- | 287.35%30.78K | ---- |
| Remuneration paid in stock | -64.08%51.45K | -40.10%6K | --0 | 50.08%168.62K | --0 | 842.99%143.25K | -71.43%10.02K | -67.15%15.36K | -85.80%112.36K | 128.31%15.36K |
| Other non cashItems | --134.41K | --297.76K | --127.38K | ---421 | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -13.81%163.87K | -96.35%8.83K | -108.64%-4.01K | -2.50%790.46K | 100.22%312.39K | 117.15%190.13K | -32.59%241.54K | -77.78%46.41K | 72.67%810.69K | 45.96%156.02K |
| -Change in receivables | -159,808.49%-169.5K | -2,695.43%-52.61K | -6.15%-16.39K | 89.74%-14.57K | 109.48%2.87K | 99.67%-106 | 70.19%-1.88K | 78.95%-15.44K | -612.23%-142.02K | -15,644.27%-30.23K |
| -Change in inventory | -94.98%186 | 223.08%546 | -13.67%120 | 81.83%2.09K | -618.92%-1.92K | 2,091.12%3.7K | 76.04%169 | -73.01%139 | 102.13%1.15K | -76.85%370 |
| -Change in prepaid assets | 0.00%4.6K | 0.00%4.6K | 0.00%4.6K | -32.25%18.38K | -15.99%4.6K | -36.35%4.6K | -36.35%4.6K | -36.35%4.6K | 139.29%27.13K | 196.37%5.47K |
| -Change in payables and accrued expense | 80.61%328.59K | -76.41%56.3K | -86.57%7.67K | -15.13%784.56K | 70.08%306.85K | 62.04%181.94K | -33.20%238.66K | -79.19%57.11K | 63.70%924.43K | 74.08%180.41K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -19.97%-196.87K | -120.11%-180.93K | -93.12%-347.77K | -9.19%-550.79K | -0.45%-124.42K | 8.67%-164.09K | -189.49%-82.2K | 38.49%-180.08K | 24.97%-504.43K | 53.28%-123.86K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -15.56K | 0 | ||||||||
| Capital expenditure reported | ---- | ---- | ---- | ---15.56K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---15.56K | ---- | ---- | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.89%188.07K | -25.28%51.41K | 179.57%486.5K | 29.81%544.97K | 32.30%117.55K | 45.85%184.59K | 1,991.94%68.81K | -16.36%174.02K | -43.26%419.82K | -64.91%88.85K |
| Net issuance payments of debt | -462.00%-411.93K | 4,012.71%51.41K | -98.75%516 | 582.88%278.45K | 20,235.40%124.66K | 21,952.91%113.79K | 98.14%-1.31K | 253.99%41.31K | -167.85%-57.66K | 102.54%613 |
| Net common stock issuance | --600K | --0 | --500K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | -100.24%-172 | -99.75%172 | -110.56%-14.02K | -44.18%266.52K | -108.05%-7.1K | -43.83%70.8K | 4.93%70.12K | -32.42%132.7K | 46.03%477.48K | 46.21%88.24K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1.79%187.9K | -25.03%51.59K | 179.57%486.5K | 29.81%544.97K | 32.30%117.55K | 45.85%184.59K | 1,991.94%68.81K | -16.36%174.02K | -43.26%419.82K | -64.91%88.85K |
| Net cash flow | ||||||||||
| Beginning cash position | 95.49%15.27K | 582.19%144.61K | -78.42%5.88K | -75.63%27.26K | -54.55%28.31K | -93.23%7.81K | -21.99%21.2K | -75.63%27.26K | 152.51%111.88K | -49.68%62.28K |
| Current changes in cash | -143.74%-8.97K | -866.11%-129.34K | 2,387.35%138.73K | 74.73%-21.38K | 35.96%-22.42K | 138.60%20.5K | -115.18%-13.39K | 92.84%-6.07K | -225.22%-84.62K | -194.43%-35.01K |
| End cash Position | -77.74%6.3K | 95.49%15.27K | 582.19%144.61K | -78.42%5.88K | -78.42%5.88K | -54.55%28.31K | -93.23%7.81K | -21.99%21.2K | -75.63%27.26K | -75.63%27.26K |
| Free cash from | -19.97%-196.87K | -120.11%-180.93K | -93.12%-347.77K | -12.27%-566.35K | -13.01%-139.98K | 8.67%-164.09K | -189.49%-82.2K | 38.49%-180.08K | 24.97%-504.43K | 53.28%-123.86K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg